Annual Net Income
-$6.58 M
+$5.96 M+47.55%
31 December 2022
Summary:
Nymox Pharmaceutical annual net profit is currently -$6.58 million, with the most recent change of +$5.96 million (+47.55%) on 31 December 2022. During the last 3 years, it has risen by +$5.16 million (+43.98%).NYMX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.39 M
-$48.00 K-3.58%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly net profit is currently -$1.39 million, with the most recent change of -$48.00 thousand (-3.58%) on 31 March 2023.NYMX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$2.88 M
+$3.70 M+56.25%
31 March 2023
Summary:
Nymox Pharmaceutical TTM net profit is currently -$2.88 million, with the most recent change of +$3.70 million (+56.25%) on 31 March 2023.NYMX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +44.0% | +57.9% | +75.5% |
| 5 y5 years | +37.9% | +43.6% | +78.2% |
NYMX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +115.6% | -188.0% | +577.4% |
Nymox Pharmaceutical Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$1.39 M(+3.6%) | -$2.88 M(-56.3%) |
| Dec 2022 | -$6.58 M(-47.5%) | -$1.34 M(-10.2%) | -$6.58 M(-18.3%) |
| Sept 2022 | - | -$1.49 M(-211.3%) | -$8.05 M(-18.3%) |
| June 2022 | - | $1.34 M(-126.3%) | -$9.85 M(-35.1%) |
| Mar 2022 | - | -$5.09 M(+81.0%) | -$15.18 M(+21.1%) |
| Dec 2021 | -$12.54 M(+6.8%) | -$2.81 M(-14.8%) | -$12.54 M(+6.7%) |
| Sept 2021 | - | -$3.30 M(-17.3%) | -$11.75 M(-6.8%) |
| June 2021 | - | -$3.99 M(+63.6%) | -$12.61 M(+9.1%) |
| Mar 2021 | - | -$2.44 M(+20.3%) | -$11.56 M(-1.5%) |
| Dec 2020 | -$11.74 M(-10.8%) | -$2.03 M(-51.2%) | -$11.74 M(-5.3%) |
| Sept 2020 | - | -$4.16 M(+41.4%) | -$12.40 M(+15.8%) |
| June 2020 | - | -$2.94 M(+12.4%) | -$10.70 M(-17.1%) |
| Mar 2020 | - | -$2.62 M(-2.7%) | -$12.91 M(-1.9%) |
| Dec 2019 | -$13.16 M(+24.2%) | -$2.69 M(+9.2%) | -$13.16 M(-0.3%) |
| Sept 2019 | - | -$2.46 M(-52.2%) | -$13.20 M(-2.4%) |
| June 2019 | - | -$5.14 M(+79.2%) | -$13.53 M(+25.2%) |
| Mar 2019 | - | -$2.87 M(+5.5%) | -$10.80 M(+1.9%) |
| Dec 2018 | -$10.59 M(-21.1%) | -$2.72 M(-2.5%) | -$10.59 M(-5.4%) |
| Sept 2018 | - | -$2.79 M(+15.4%) | -$11.20 M(-13.8%) |
| June 2018 | - | -$2.42 M(-9.2%) | -$12.99 M(-2.2%) |
| Mar 2018 | - | -$2.66 M(-20.0%) | -$13.28 M(-1.1%) |
| Dec 2017 | -$13.43 M(+2.4%) | -$3.33 M(-27.4%) | -$13.43 M(+3.8%) |
| Sept 2017 | - | -$4.58 M(+69.4%) | -$12.94 M(+12.7%) |
| June 2017 | - | -$2.71 M(-3.9%) | -$11.48 M(-8.9%) |
| Mar 2017 | - | -$2.81 M(-0.7%) | -$12.60 M(-3.9%) |
| Dec 2016 | -$13.11 M(-26.7%) | -$2.83 M(-9.3%) | -$13.11 M(-8.9%) |
| Sept 2016 | - | -$3.13 M(-18.3%) | -$14.39 M(-32.3%) |
| June 2016 | - | -$3.83 M(+15.0%) | -$21.27 M(-6.7%) |
| Mar 2016 | - | -$3.33 M(-19.2%) | -$22.80 M(+27.4%) |
| Dec 2015 | -$17.89 M(+289.5%) | -$4.11 M(-58.9%) | -$17.89 M(+25.4%) |
| Sept 2015 | - | -$10.01 M(+87.0%) | -$14.27 M(+188.1%) |
| June 2015 | - | -$5.35 M(-439.3%) | -$4.95 M(+1066.5%) |
| Mar 2015 | - | $1.58 M(-419.9%) | -$424.70 K(-90.8%) |
| Dec 2014 | -$4.59 M(-6.4%) | -$492.80 K(-28.4%) | -$4.59 M(-15.2%) |
| Sept 2014 | - | -$688.20 K(-16.1%) | -$5.42 M(-5.8%) |
| June 2014 | - | -$820.30 K(-68.4%) | -$5.75 M(-10.3%) |
| Mar 2014 | - | -$2.59 M(+96.9%) | -$6.41 M(+30.5%) |
| Dec 2013 | -$4.91 M(-35.6%) | -$1.32 M(+29.1%) | -$4.91 M(-23.4%) |
| Sept 2013 | - | -$1.02 M(-30.9%) | -$6.41 M(-3.4%) |
| June 2013 | - | -$1.48 M(+35.1%) | -$6.63 M(-3.5%) |
| Mar 2013 | - | -$1.09 M(-61.1%) | -$6.87 M(-9.9%) |
| Dec 2012 | -$7.63 M(-21.0%) | -$2.81 M(+125.9%) | -$7.63 M(+17.8%) |
| Sept 2012 | - | -$1.25 M(-27.6%) | -$6.47 M(-5.4%) |
| June 2012 | - | -$1.72 M(-6.8%) | -$6.84 M(-3.2%) |
| Mar 2012 | - | -$1.85 M(+11.3%) | -$7.07 M(-26.8%) |
| Dec 2011 | -$9.65 M(+47.7%) | -$1.66 M(+2.8%) | -$9.65 M(-4.0%) |
| Sept 2011 | - | -$1.61 M(-17.2%) | -$10.05 M(-0.3%) |
| June 2011 | - | -$1.95 M(-56.0%) | -$10.09 M(+3.1%) |
| Mar 2011 | - | -$4.43 M(+115.4%) | -$9.78 M(+49.7%) |
| Dec 2010 | -$6.54 M | -$2.06 M(+24.8%) | -$6.54 M(+8.5%) |
| Sept 2010 | - | -$1.65 M(+0.2%) | -$6.02 M(+5.0%) |
| June 2010 | - | -$1.65 M(+39.1%) | -$5.74 M(+8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$1.18 M(-23.3%) | -$5.31 M(+3.5%) |
| Dec 2009 | -$5.13 M(+10.6%) | -$1.54 M(+13.2%) | -$5.13 M(+13.9%) |
| Sept 2009 | - | -$1.36 M(+11.7%) | -$4.50 M(+0.3%) |
| June 2009 | - | -$1.22 M(+21.5%) | -$4.49 M(+1.9%) |
| Mar 2009 | - | -$1.00 M(+9.6%) | -$4.41 M(-4.9%) |
| Dec 2008 | -$4.64 M(-12.3%) | -$916.40 K(-32.1%) | -$4.64 M(-7.7%) |
| Sept 2008 | - | -$1.35 M(+18.7%) | -$5.02 M(-0.7%) |
| June 2008 | - | -$1.14 M(-7.6%) | -$5.06 M(-6.0%) |
| Mar 2008 | - | -$1.23 M(-5.5%) | -$5.38 M(+1.9%) |
| Dec 2007 | -$5.29 M(+8.1%) | -$1.30 M(-6.1%) | -$5.29 M(+1.4%) |
| Sept 2007 | - | -$1.39 M(-5.1%) | -$5.21 M(+2.9%) |
| June 2007 | - | -$1.46 M(+29.2%) | -$5.07 M(+2.0%) |
| Mar 2007 | - | -$1.13 M(-8.1%) | -$4.97 M(+1.5%) |
| Dec 2006 | -$4.89 M(+36.5%) | -$1.23 M(-0.7%) | -$4.89 M(+9.1%) |
| Sept 2006 | - | -$1.24 M(-9.0%) | -$4.49 M(+6.7%) |
| June 2006 | - | -$1.36 M(+28.4%) | -$4.20 M(+13.9%) |
| Mar 2006 | - | -$1.06 M(+28.8%) | -$3.69 M(+2.9%) |
| Dec 2005 | -$3.58 M(-4.3%) | -$824.00 K(-13.9%) | -$3.59 M(-3.3%) |
| Sept 2005 | - | -$957.50 K(+12.8%) | -$3.71 M(+7.6%) |
| June 2005 | - | -$849.00 K(-11.3%) | -$3.45 M(-7.9%) |
| Mar 2005 | - | -$957.30 K(+1.1%) | -$3.74 M(-0.2%) |
| Dec 2004 | -$3.75 M(-14.0%) | -$947.10 K(+36.4%) | -$3.75 M(-12.0%) |
| Sept 2004 | - | -$694.30 K(-39.3%) | -$4.26 M(-3.4%) |
| June 2004 | - | -$1.14 M(+18.6%) | -$4.41 M(+0.4%) |
| Mar 2004 | - | -$964.10 K(-33.9%) | -$4.40 M(+0.8%) |
| Dec 2003 | -$4.35 M(+27.2%) | -$1.46 M(+72.4%) | -$4.36 M(+14.8%) |
| Sept 2003 | - | -$846.20 K(-24.9%) | -$3.80 M(+1.2%) |
| June 2003 | - | -$1.13 M(+21.2%) | -$3.75 M(+8.2%) |
| Mar 2003 | - | -$929.30 K(+3.8%) | -$3.47 M(+1.4%) |
| Dec 2002 | -$3.42 M(+12.2%) | -$895.30 K(+11.9%) | -$3.42 M(-2.8%) |
| Sept 2002 | - | -$799.80 K(-5.1%) | -$3.52 M(+3.0%) |
| June 2002 | - | -$843.00 K(-4.4%) | -$3.42 M(+2.7%) |
| Mar 2002 | - | -$882.20 K(-11.3%) | -$3.33 M(+9.1%) |
| Dec 2001 | -$3.05 M(-24.2%) | -$994.50 K(+42.9%) | -$3.05 M(-0.5%) |
| Sept 2001 | - | -$696.00 K(-7.6%) | -$3.06 M(-6.9%) |
| June 2001 | - | -$753.50 K(+24.6%) | -$3.29 M(-13.2%) |
| Mar 2001 | - | -$604.50 K(-40.1%) | -$3.79 M(-5.7%) |
| Dec 2000 | -$4.02 M(+21.4%) | -$1.01 M(+9.1%) | -$4.02 M(+2.4%) |
| Sept 2000 | - | -$924.20 K(-26.3%) | -$3.93 M(+3.3%) |
| June 2000 | - | -$1.25 M(+50.5%) | -$3.80 M(+24.9%) |
| Mar 2000 | - | -$833.50 K(-9.0%) | -$3.05 M(-5.2%) |
| Dec 1999 | -$3.31 M(-30.7%) | -$916.20 K(+14.6%) | -$3.21 M(-12.5%) |
| Sept 1999 | - | -$799.40 K(+60.7%) | -$3.67 M(-9.9%) |
| June 1999 | - | -$497.50 K(-50.3%) | -$4.08 M(-12.9%) |
| Mar 1999 | - | -$1.00 M(-27.2%) | -$4.68 M(-6.0%) |
| Dec 1998 | -$4.78 M(+36.8%) | -$1.37 M(+14.3%) | -$4.98 M(+15.8%) |
| Sept 1998 | - | -$1.20 M(+9.3%) | -$4.30 M(+5.0%) |
| June 1998 | - | -$1.10 M(-15.3%) | -$4.10 M(+5.2%) |
| Mar 1998 | - | -$1.30 M(+86.3%) | -$3.90 M(+14.6%) |
| Dec 1997 | -$3.50 M | -$697.30 K(-30.2%) | -$3.40 M(+25.8%) |
| Sept 1997 | - | -$999.70 K(+11.1%) | -$2.70 M(+58.7%) |
| June 1997 | - | -$899.80 K(+12.1%) | -$1.70 M(+112.1%) |
| Mar 1997 | - | -$802.80 K | -$802.80 K |
FAQ
- What is Nymox Pharmaceutical annual net profit?
- What is the all time high annual net income for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly net profit?
- What is the all time high quarterly net income for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical TTM net profit?
- What is the all time high TTM net income for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual net profit?
The current annual net income of NYMX is -$6.58 M
What is the all time high annual net income for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual net profit is -$3.05 M
What is Nymox Pharmaceutical quarterly net profit?
The current quarterly net income of NYMX is -$1.39 M
What is the all time high quarterly net income for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly net profit is $1.58 M
What is Nymox Pharmaceutical TTM net profit?
The current TTM net income of NYMX is -$2.88 M
What is the all time high TTM net income for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high TTM net profit is -$424.70 K